PrEP With TDF/FTC to Prevent HIV-1 Acquisition in Young MSM and Transgender Women of Color
NCT02367807
·
clinicaltrials.gov ↗
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
HIV
Interventions
DRUG:
Emtricitabine and tenofovir disoproxil fumarate
Sponsor
Philadelphia Fight